Amelioration of age‐related brain function decline by Bruton's tyrosine kinase inhibition-Reference-Cited by-同舟云学术

Amelioration of age‐related brain function decline by Bruton's tyrosine kinase inhibition

Published:2019-11-17 Issue:1 Volume:19 Page:
ISSN:1474-9718
Container-title:Aging Cell
language:en
Short-container-title:Aging Cell

Author:

Ekpenyong‐Akiba Akang E.¹,Poblocka Marta¹,Althubiti Mohammad¹²,Rada Miran¹,Jurk Diana³⁴⁵,Germano Sandra¹,Kocsis‐Fodor Gabriella¹,Shi Yu¹,Canales Juan J.⁶,Macip Salvador¹^ORCID

Affiliation:

1. Mechanisms of Cancer and Aging Laboratory Department of Molecular and Cell Biology University of Leicester Leicester UK

2. Department of Biochemistry Faculty of Medicine Umm Al‐Qura University Mecca Saudi Arabia

3. Ageing Research Laboratories Institute for Ageing and Health Newcastle University Newcastle upon Tyne UK

4. Centre for Integrated Systems Biology of Ageing and Nutrition Institute for Ageing and Health Newcastle University Newcastle upon Tyne UK

5. Department of Physiology and Biomedical Engineering, Robert and Arlene Kogod Center on Aging Mayo Clinic Rochester MN USA

6. Division of Psychology School of Medicine University of Tasmania Hobart TAS Australia

Publisher

Wiley

Subject

Cell Biology,Aging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acel.13079

Reference47 articles.

1. Bruton’s tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib

2. Characterization of novel markers of senescence and their prognostic potential in cancer

3. Detection of Senescent Cells by Extracellular Markers Using a Flow Cytometry-Based Approach

4. BTK Modulates p53 Activity to Enhance Apoptotic and Senescent Responses

5. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Dietary Consumption of Grapes Affects Kidney Health in C57BL/6J Mice;Nutrients;2024-07-18

2. A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageing;Biochemical Society Transactions;2024-06-28

3. Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic;Aging;2023-03-28

4. FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders;Pharmaceuticals;2022-12-13

5. Identification of proteomic landscape of drug-binding proteins in live cells by proximity-dependent target ID;Cell Chemical Biology;2022-12